Seasonal influenza (flu) is an acute respiratory infection which can affect up to 20% of the general community each year. Older adults who become infected with the flu are at a significantly elevated risk of complications compared to adults of a younger age. Complications can include secondary bacterial infections such as pneumonia, sinusitis and otitis media, as well as conditions related to ischaemic cardiomyopathy, cerebrovascular disease and diabetes. Hospitalisation and death due to influenza infection is also more common among high-risk groups. Most deaths associated with influenza in countries like Australia occur among individuals who are 65 years of age or older.The most important prevention measure for influenza and its complications is yearly vaccination. Australian immunisation guidelines currently recommend one annual dose of influenza vaccination for people aged 65 years and over. Vaccinating older adults can reduce the severity of disease, the rate of hospitalisation from influenza and pneumonia, and all-cause mortality.
Pharmacist-led flu vaccinations in adults 65 years and over: challenges and strategies – The Australian Pharmacy Council
Australie
$0
gratuit
1 heure
Maladie infectieuse
2 Credits
Description du cours
Détails du cours
Date d'expiration : 2020-06-25
Métiers: Pharmacie
Faculté
Anthony Tassone
BPharm(Hons), AACPA, GAICD
Pharmacist
President, Pharmacy Guild of Australia, Victoria Branch, Melbourne
Accréditation
This activity has been accredited for 1.00 hour(s) of Group 2 CPD (or 2 CPD Credits) suitable for inclusion in an individual pharmacist’s CPD plan
Objectif(s) d'apprentissage
After completing this education, pharmacists will be better able to:
- Demonstrate an understanding of the challenges facing older adults with influenza vaccination particularly immunosenescence, the H3N2 strain and its tendency to undergo antigenic drift
- Describe the mechanism of action, efficacy and safety of enhanced influenza vaccines in the population 65 years and over
- Differentiate between the standard quadrivalent influenza vaccines (QIVs) and enhanced trivalent influenza vaccines and which vaccine is recommended in specific age groups